Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting.
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: catriona.mckenzie@sswahs.nsw.gov.au.
Catriona A
CA
McKenzie
Dermatology and Bosch Institute, The University of Sydney at Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Andrew C
AC
Chen
Dermatology, The University of Sydney at Westmead Hospital, Sydney, NSW, Australia.
Bonita
B
Choy
Dermatology, The University of Sydney at Westmead Hospital, Sydney, NSW, Australia.
Pablo
P
Fernández-Peñas
Dermatology and Bosch Institute, The University of Sydney at Royal Prince Alfred Hospital, Sydney, NSW, Australia; Melanoma Institute Australia, North Sydney, Sydney, NSW, Australia.
Diona L
DL
Damian
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Melanoma Institute Australia, North Sydney, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia.
Richard A
RA
Scolyer
D002280:Basal Cell Carcinoma / Q000145:classification* / Q000473:pathology; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D012878:Skin Neoplasms / Q000145:classification* / Q000473:pathology